Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
about
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxisPlasminogen is tethered with high affinity to the cell surface by the plasma protein, histidine-rich glycoproteinBinding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPARA role of histone H3 lysine 4 methyltransferase components in endosomal traffickingThe plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesVascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsMannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interactionChanges in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerThe ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in actionIdentification of the disulfide bonds in the recombinant somatomedin B domain of human vitronectinPleural mesothelial cells in pleural and lung diseasesExpression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour sizeMyosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptorElevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.In silico docking of urokinase plasminogen activator and integrins.Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient miceModulation of platelet caspases and life-span by anti-platelet antibodies in mice.Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype.Tissue inhibitors of matrix metalloproteinases in cancer.Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines.Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytesInvolvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumoniaTargeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia.Urokinase plasminogen receptor and the fibrinolytic complex play a role in nerve repair after nerve crush in mice, and in human neuropathies.Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.Molecular mechanisms of fibrinolysis.Post-transcriptional regulation of gene expression in the plasminogen activation system.Mechanisms of tumour invasion and metastasis: emerging targets for therapy.Identification of altered plasma proteins by proteomic study in valvular heart diseases and the potential clinical significanceA role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitisThe plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.Analysis of Paracoccidioides secreted proteins reveals fructose 1,6-bisphosphate aldolase as a plasminogen-binding proteinPlasminogen activator/plasmin system: a major player in wound healing?Migration of keratinocytes through tunnels of digested fibrin.Membrane associated proteases and their inhibitors in tumour angiogenesis.CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.
P2860
Q22253459-D05EA340-C8A3-409F-A54E-93A3E1053EE3Q24297996-64F08FE9-68B8-43FA-9BCC-9C66BB16044DQ24298783-5CB3C6E8-1569-4FA1-8AFA-85FC80C74B50Q24320194-D22C2938-B1A2-429B-9B64-CD4BE77746F8Q24671642-880628B3-5E47-40F9-BD71-18C96E1A456FQ24679724-417BE129-4F31-4107-A848-604CD9F4A022Q24683196-30E93A64-5456-4AEF-AD25-A6273C1B04B1Q24807354-A0C01827-B8D8-4268-89A4-5723721D03F1Q27765730-DA1CF58B-6772-4332-89AB-031D841C6B47Q28218295-17FBDD78-7F89-4BDD-84E2-2DA7C601135CQ28396403-4AE73060-4C19-4C22-8AB9-9A75FEBDE95BQ28565213-A380CB00-BC0F-43CF-A51A-88E4BF51BDD3Q30304130-27A31F8F-3983-4650-89E4-25C773699DA6Q30493647-95C661D9-4A75-4F6D-96B1-6C889D104ADFQ31038443-648CFDBF-0063-4635-ADDC-708E83C25C98Q33326906-0520BAA5-6CC5-4872-A1BB-BD34EAF86FC3Q33332861-D9AD1AC4-2984-4C18-9AC6-CA33B8D62071Q33343413-291490CE-8422-4FAC-B5C9-4D707363F664Q33687878-C851BE55-B6B3-4BB7-8E01-86377E1A9B51Q33692913-164642E1-0F0F-47BA-9B66-E3773FDD4B6EQ33841604-911B177B-66C2-48E3-B3DF-4FBCB674A22AQ33943133-DCD484F3-3A40-4E40-9893-47E4A060F48AQ33946698-4A9AAF67-5769-4D7C-9105-CE7361150307Q33948206-868647FD-1892-4563-979E-A8E70B7A75FCQ34009345-768CC61F-55B6-4973-BBFD-5B19468A0FCBQ34022566-F6F866AD-1BAD-4BA2-BBB5-4CCF66674D79Q34075984-B19CEFDF-9A03-4C96-89B1-B5C7356CC13AQ34171622-6ED6082D-E19C-4617-BEBF-C7BCF0E57C31Q34293732-E2400B2F-0AE1-4327-9FC3-E1915430259CQ34412757-873C4283-734E-4D69-A48B-6737CC028822Q34584801-06C14193-8917-4117-B61D-400CBDD27F84Q34837655-1AB4365D-07F9-4330-8B7A-441FB909B513Q34981365-4636E26D-081D-419B-B679-DF37323EBA60Q35085079-2BD500CF-D729-46E0-982C-A002B52D2DEFQ35096108-D9978DF6-D51F-4E0C-BD27-E87D6D49C13DQ35169853-F728DEAE-79F9-4FBB-8769-6139AA90D39FQ35170968-C4FBF349-04E9-4CE6-AECA-7663BC05C747Q35266509-ACCF0320-8662-42A7-BEB7-85594368ED1BQ35587684-B713B7CC-1F2B-45D5-8552-73DE41F5FDC1Q35606333-F05D8A5B-AF0D-419F-9E48-38DA550F0229
P2860
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
description
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1997
@ast
im Oktober 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/10/01)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/10/01)
@nl
наукова стаття, опублікована в жовтні 1997
@uk
مقالة علمية (نشرت في أكتوبر 1997)
@ar
name
Plasminogen activators, integr ...... of cell adhesion and migration
@ast
Plasminogen activators, integr ...... of cell adhesion and migration
@en
Plasminogen activators, integr ...... of cell adhesion and migration
@nl
type
label
Plasminogen activators, integr ...... of cell adhesion and migration
@ast
Plasminogen activators, integr ...... of cell adhesion and migration
@en
Plasminogen activators, integr ...... of cell adhesion and migration
@nl
prefLabel
Plasminogen activators, integr ...... of cell adhesion and migration
@ast
Plasminogen activators, integr ...... of cell adhesion and migration
@en
Plasminogen activators, integr ...... of cell adhesion and migration
@nl
P1476
Plasminogen activators, integr ...... of cell adhesion and migration
@en
P2093
H. A. Chapman
P304
P356
10.1016/S0955-0674(97)80126-3
P577
1997-10-01T00:00:00Z